Ovarian cancer mostly has changes of type II glycosylated antigens, such as Lewis x, Lewis y and H antigens, which mainly depend on the α1, 2-FT-catalyzed fucosylation of galactose residues at the non-reducing terminal [19]. The gene discussed is FUT4; the disease is ovarian cancer.